Clinical trial
Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy
NCT00299884 · Queen's University, Other · Completed
Key facts
| NCT number | NCT00299884 |
|---|---|
| Title | Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy |
| Official title | The Comparison of the Efficacy of Ezetimibe and Fenofibrate Versus Atorvastatin Alone in the Lowering of LDL Cholesterol |
| Lead sponsor | Queen's University, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Dyslipidemia, Vascular Disease |
| Intervention type | Drug |
| Interventions | Lipitor 20 mg, Combination Ezetrol 10 mg and Lipidil Supra 160 mg |
| Enrollment | 45 |
| Start date | Jan 1, 2005 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Mar 7, 2006 |
| Last update posted | Mar 29, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: